Bahija Jallal, Ph.D.

Bahija Jallal, Ph.D.

Chief Executive OfficeratImmunocore Holdings· In proxies 2021–2023

Pay in FY2023+46% from the year before · Immunocore Holdings stock +19.7% the same year

Bahija Jallal, Ph.D. was paid $11.7M in FY2023 (Dec), up 46%. Immunocore Holdings stock rose 19.7% that year.

Pay$100 in the stock at the end of FY21 → $200
Pay is from the Summary Compensation Table of each Immunocore Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Immunocore HoldingsPublic company · 5 yr
    • Chief Executive Officer2021 – Present · 5 yrStock in role -25%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?